BackSanten Pharmaceutical , Ltd. Overview

Santen Pharmaceutical , Ltd. Profit Margin

Valuation check: SNPHF's profit margin is 13.1%, below the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

11.10%
↓ 4.78% YoY

As of Sep 2026

Annual Profit Margin (TTM)

13.10%
↑ 21.47% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Santen Pharmaceutical , Ltd. (SNPHF) FAQ

Santen Pharmaceutical , Ltd. posts a profit margin of 13.1% as of September 2026. That compares with 10.78% in the prior-year period — up 21.5% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Santen Pharmaceutical , Ltd.'s profit margin was 10.78%. The latest reading is 13.1% — a 21.5% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.4% is typical. Santen Pharmaceutical , Ltd.'s 13.1% is lower that level. That is roughly 2.3% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Santen Pharmaceutical , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 13.1% as of September 2026; use YoY and peer views to separate noise from signal.

Context for SNPHF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; Santen Pharmaceutical , Ltd.'s other metric pages and overview cover the third.